Combination therapy for moderate to severe ulcerative colitis
Part of Digestive system clinical trials.
This study tests a new combination of two drugs to see if they are safe and help reduce ulcerative colitis symptoms. It is for people who have not gotten enough relief from other treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 40 kg (about 88 pounds).
- You have had ulcerative colitis for at least 3 years.
- Your disease is moderate to severe, with active inflammation visible on a scope test.
- You have not responded well to previous biologic or JAK inhibitor treatments.
- You are willing to attend study visits and follow the study procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational drug for people with active mild-to-moderate ulcerative colitis. It aims to see if the drug can improve symptoms without needing advanced treatments like biologics.
This study tests several new treatments to see if they are safe and helpful for people with moderate to severe ulcerative colitis. If you have not responded well to standard treatments, this might be an option.
This study tests an experimental tablet for people with moderate to severe ulcerative colitis that hasn't improved with standard treatments. It aims to see if the tablet can reduce symptoms and inflammation.
This trial tests a new medicine (TQH3906) for people with moderate to severe ulcerative colitis or Crohn's disease that hasn't improved with other treatments. The goal is to see if it can help control inflammation in the gut.
This study is testing an investigational medication for moderate to severe ulcerative colitis (UC) that has not responded well to other treatments. The goal is to see if the drug can help reduce inflammation and improve symptoms.
This study tests an experimental drug called HSK47388 for people with moderate to severe ulcerative colitis who have not had good results from other treatments. The goal is to see if it can reduce inflammation and improve symptoms.
Hear when a new Colitis, Ulcerative trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.